T7.2/Design: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
 
(26 intermediate revisions by the same user not shown)
Line 23: Line 23:


===Ribosome Binding Sites===
===Ribosome Binding Sites===
We will use a standardized set of ribosomes known to have different levels of expression.  We will replace the natural sites with sites that are encoded by the BioBrick part numbers: <br>
We will standardize the use of Ribosome binding sites (RBS).  We will assign one of these parts to each coding domain based on both knowledge of the amounts of total protein production necessary, as well as computational analysis of the existing ribosome binding sites strength.  We will standardize to ribosome binding sites that were characterized by initial experiments by Heather Keller to experimentally charactize all the natural RBS strengths: <br>
[http://parts2.mit.edu/r/parts/partsdb/view.cgi?part_id=151 BBa_B0034] -- strongest 1 <br>
[http://parts2.mit.edu/r/parts/partsdb/view.cgi?part_id=147 BBa_B0030] -- strong 0.6 <br>
[http://parts2.mit.edu/r/parts/partsdb/view.cgi?part_id=149 BBa_B0032] -- medium 0.3 <br>
[http://parts2.mit.edu/r/parts/partsdb/view.cgi?part_id=148 BBa_B0031] -- weak 0.07 <br>
[http://parts2.mit.edu/r/parts/partsdb/view.cgi?part_id=150 BBa_B0033] -- weaker 0.01 <br>


We will assign one of these parts to each coding domain based on both knowledge of the amounts of total protein production necessary, as well as computational analysis of the existing ribosome binding sites strength.
'''<bbpart>Z0261</bbpart> -- strong RBS '''-- based on gene 5 RBS<br>
'''<bbpart>Z0262</bbpart> -- medium RBS '''-- based on [http://parts2.mit.edu/r/parts/partsdb/view.cgi?part_id=147 BBa_B0030]<br>


For details on individual genes, check out the [[T7.2/gene specification|gene specification]] page.
For details on individual genes, check out the [[T7.2/gene specification|gene specification]] page.
Line 36: Line 32:
===Host Promoters===
===Host Promoters===
We will encode only the the 3 strong host promoters, A1, A2, and A3.  We will actively take steps to remove the other host promoters identified in the [[T7.1/Reannotation|annotation]].  Finally, we will keep the ''boxA'' anti-termination site intact.  It is worth considering if we should remove all but one of the T7 promoters, such as A1.
We will encode only the the 3 strong host promoters, A1, A2, and A3.  We will actively take steps to remove the other host promoters identified in the [[T7.1/Reannotation|annotation]].  Finally, we will keep the ''boxA'' anti-termination site intact.  It is worth considering if we should remove all but one of the T7 promoters, such as A1.
'''A1,A2,A3,BoxA region -- <bbpart>Z0294</bbpart>'''<br>
====Removed Host Promoters====
'''B''': Located mostly in gene 0.5, which is not encoded<br>
'''C''': Only -35 region is included within coding domain of gene 0.7; no further mutation necessary<br>
'''E''': Strong -10 region mutated, -35 region not included<br>
'''S1''': -35 and -10 regions edited to remove promoter<br>
'''S2''': -35 region edited, -10 region already nonoptimal<br>
'''S3''': -35 and -10 regions edited to remove promoter<br>
'''S4''': -35 and -10 regions edited to remove promoter<br>
'''S5''': Located within gene 5.3 which is not included<br>
'''S6''': -35 and -10 regions edited to remove promoter<br>
'''F1''': Only -35 region is included within coding domain of gene 6.5; no further mutation necessary<br>
'''F2''': -35 region mutated, -10 region already nonoptimal<br>


===Phage Promoters===
===Phage Promoters===
We want to standardize the phage promoters that we encode onto the genome.  In our models, we split the promoters into three class; weak binding and processivity, weak processivity, or strong promoters.  The natural T7 promoters on the T7 genome are listed below, along the classification they fall into.  The promoters in bold are the canonical promoter in each class that have the most kinetic studies associated with them.  Thus we will use the three promoters in bold as the prototype sequences in each class that we will standardize the other promoters to. <br>
We want to standardize the phage promoters that we encode onto the genome.  In our models, we split the promoters into three class; weak binding and processivity, weak processivity, or strong promoters.  The natural T7 promoters on the T7 genome are listed below, along the classification they fall into.  The promoters in bold are the canonical promoter in each class that have the most kinetic studies associated with them.  Thus we will use the three promoters in bold as the prototype sequences in each class that we will standardize the other promoters to. <br>
øOL -- weak processivity (-11,1)<br>
øOL -- weak processivity (-11,1) -- standardized to <bbpart>Z0253</bbpart><br>
ø1.1A -- weak binding & processivity (-17,2,4)<br>
ø1.1A -- weak binding & processivity (-17,2,4) -- standardized to <bbpart>Z0252</bbpart><br>
ø1.1B -- weak processivity (3,4,5)<br>
ø1.1B -- weak processivity (3,4,5) -- standardized to <bbpart>Z0253</bbpart><br>
ø1.3 -- weak binding & processivity (-5,5)<br>
ø1.3 -- weak binding & processivity (-5,5) -- standardized to <bbpart>Z0252</bbpart><br>
ø1.5 -- weak processivity (-2,3,4,5)<br>
ø1.5 -- weak processivity (-2,3,4,5) -- standardized to <bbpart>Z0253</bbpart><br>
ø1.6 -- weak processivity (-2,3,4,5,6)<br>
ø1.6 -- weak processivity (-2,3,4,5,6) -- standardized to <bbpart>Z0253</bbpart><br>
'''ø2.5''' -- weak processivity (-1,1,4,5)<br>
'''ø2.5 -- weak processivity (-1,1,4,5) -- defined as <bbpart>Z0253</bbpart>'''<br>  
'''ø3.8''' -- weak binding & processivity (-13,-12,-11,-2)<br>
'''ø3.8 -- weak binding & processivity (-13,-12,-11,-2) -- defined as <bbpart>Z0252</bbpart>'''<br>
ø4c -- weak binding & processivity (-17,-13,2)<br>
ø4c -- weak binding & processivity (-17,-13,2) -- standardized to <bbpart>Z0252</bbpart><br>
ø4.3 -- weak processivity (-2,3,4,5,6)<br>
ø4.3 -- weak processivity (-2,3,4,5,6) -- standardized to <bbpart>Z0253</bbpart><br>
ø4.7 -- weak binding & processivity (-17,-16,-13,3,4,5,6)<br>
ø4.7 -- weak binding & processivity (-17,-16,-13,3,4,5,6) -- standardized to <bbpart>Z0252</bbpart><br>
ø6.5 -- strong<br>
ø6.5 -- strong -- standardized to <bbpart>Z0251</bbpart><br>
ø9 -- strong<br>
ø9 -- strong -- standardized to <bbpart>Z0251</bbpart><br>
'''ø10''' -- strong<br>
'''ø10 -- strong -- defined as <bbpart>Z0251</bbpart>'''<br>
ø13 -- strong<br>
ø13 -- strong -- standardized to <bbpart>Z0251</bbpart><br>
ø17 -- strong<br>
ø17 -- strong -- standardized to <bbpart>Z0251</bbpart><br>
øOR -- strong<br>
øOR -- strong -- standardized to <bbpart>Z0251</bbpart><br>


===Terminators===
===Terminators===
We will keep our defiinitions for the terminators as they were in [[T7.1]].  TE and Tø will remain intact, while effort will be made to not alter the CJ terminator.
We will keep our defiinitions for the terminators as they were in [[T7.1]].  TE and Tø will remain intact, while effort will be made to not alter the CJ terminator.
'''TE -- <bbpart>Z0271</bbpart>'''<br>
'''Tø -- <bbpart>Z0272</bbpart>'''<br>


===RNA===
===RNA===
====RNaseIII sites====
====RNaseIII sites====
====standardizing RNA ends====
We will use the R0.3 as a standard RNaseIII site for all encoded RnaseIII sites in T7.2 (except R1.1, which lies in the primary origin of replication).
 
'''R0.3 -- <bbpart>Z0273</bbpart>'''<br>
===Miscellaenous Elements===
====Terminal Repeats====
'''Left End -- <bbpart>Z0292</bbpart>'''<br>
'''Right End -- <bbpart>Z0293</bbpart>'''<br>
====Primary Origin of Replication====
The primary origin of replication is located at the phi1.1A/R1.1/phi1.1B locus.  In order to not disturb this critical section of the T7 genome, we will not standardize the promoters or RNAseIII site located in this section. 
 
'''Primary Origin of Replication -- <bbpart>Z0291</bbpart>'''<br>
 
===Other Changes===
===Other Changes===
====Reporters====
====Reporters====
Line 72: Line 97:


====Restriction enzyme considerations====
====Restriction enzyme considerations====
==Assemblies==
===Component Makeups===
====In Words====
Left End -- Phi2.5 -- A1,A2,A3,BoxA -- R0.3 -- 0.3 -- R0.3 -- 0.7 -- R0.3 -- 1 -- ORI -- 1.1 -- 1.2 -- phi 3.8 -- R0.3 -- 1.3 -- TE -- phi2.5 -- 1.7 -- 2 -- phi2.5 -- 2.5 -- 3 -- 3.5 -- R0.3 -- phi3.8 -- 4A/B -- phi2.5 -- 4.3 -- 4.5 -- R0.3 -- phi3.8 -- 5 -- 5.5 -- 5.7 -- 6 -- R0.3 -- phi10 -- 6.5 -- 6.7 - 7.3 -- 8 -- phi10 -- 9 -- phi10 -- 10 -- Tphi -- 11 -- 12 -- R0.3 -- phi10 -- 13 -- 14 -- 15 -- 16 -- phi10 -- 17 -- 17.5 -- 18 -- R0.3 -- 18.5/18.7 -- 19/19.2/19.3 -- phi10 -- 19.5 -- Right End
====In BioBrick Numbers====
Z0292.Z0253.Z0294.Z0273.Z0261.Z0158.Z0273.Z0262.Z0106.Z0273.Z0262.Z0107.Z0291.Z0262.
Z0108.Z0261.Z0115.Z0252.Z0273.Z0261.Z0109.Z0271.Z0253.Z0262.Z0151.Z0261.Z0116.Z0253.
Z0262.Z0152.Z0262.Z0118.Z0262.Z0119.Z0273.Z0252.Z0262.Z0120.Z0253.Z0261.Z0138.Z0261.
Z0139.Z0273.Z0252.Z0261.Z0121.Z0261.Z0160.Z0261.Z0154.Z0273.Z0251.Z0262.Z0159.Z0261.
Z0123.Z0262.Z0124.Z0262.Z0125.Z0251.Z0262.Z0126.Z0251.Z0261.Z0127.Z0272.Z0261.Z0128.
Z0262.Z0129.Z0273.Z0251.Z0262.Z0155.Z0262.Z0156.Z0262.Z0132.Z0262.Z0133.Z0251.Z0262.
Z0134.Z0262.Z0157.Z0261.Z0136.Z0273.Z0261.Z0144.Z0262.Z0137.Z0251.Z0261.Z0148.Z0293
====Initial Design====
'''Initial Compilation: <bbpart>Z0501</bbpart>'''

Latest revision as of 12:43, 30 May 2006

Project pages on
Rebuilding T7

T7.1
Reannotation
Specification
Construction
Evolution

T7.2
Design

back to Endy Lab

T7.2 Alpha Design

Design

An initial draft design of T7.2

Based on the gene, RBS, RNaseIII, and promoter classifications described below, I have constructed a draft design shown in the thumbnail to the right. This is the component level specificaiton. Further refinement will be needed at the sequence level (DpnI optimization, restriction sites, codon shuffling, and how much extra DNA we will have to add).

Comments

Sri Kosuri 19:17, 28 March 2006 (EST): I'm wondering what to do when there are there are elements removed that cause two promoter elements to be right next to each other. For example, in this initial design, ø1.5 and ø1.6 (standardized to ø2.5) are right next to each other because we are planning to eliminate 1.5.

Sri Kosuri 19:35, 28 March 2006 (EST): By the definition of what coding domains we are keeping and removing (below), I think we should probably get rid of 0.3. Is there any other assignable function for this gene other than host restriction evasion?

Functional Genetic Element Design Considerations

Coding Domains

A number of the CDS on the natural T7 genome that do not contribute to phage development in the set of conditions that we wish to assay them, and thus confound our systems-level analysis. We would like to remove a number of genes which we have reason to believe encode no observable function.

The following genes are unconserved across other T7 likes and encode no known function during T7 development: 0.4, 0.5, 0.6A/B, 1.4, 1.5, 1.6, 1.8, 2.8, 3.8, 4.1, 4.2, 4.7, 5.3, 5.9, 6.3, 7, 7.7. We will begin by removing these genes first.

There is a larger subset of genes that we are interested in removing, but will continue to keep these in the genome for a variety of reasons (evolutionary conservation, contribution to development unclear). We will it make easier to delete them in the future. This subset include genes 0.3, 1.1, 4.3, 4.5, 5.5-5.7, 5.7, 6.5, 18.5, 18.7, 19.2, 19.3, 19.5.

For details on individual genes, check out the gene specification page.

Ribosome Binding Sites

We will standardize the use of Ribosome binding sites (RBS). We will assign one of these parts to each coding domain based on both knowledge of the amounts of total protein production necessary, as well as computational analysis of the existing ribosome binding sites strength. We will standardize to ribosome binding sites that were characterized by initial experiments by Heather Keller to experimentally charactize all the natural RBS strengths:

<bbpart>Z0261</bbpart> -- strong RBS -- based on gene 5 RBS
<bbpart>Z0262</bbpart> -- medium RBS -- based on BBa_B0030

For details on individual genes, check out the gene specification page.

Host Promoters

We will encode only the the 3 strong host promoters, A1, A2, and A3. We will actively take steps to remove the other host promoters identified in the annotation. Finally, we will keep the boxA anti-termination site intact. It is worth considering if we should remove all but one of the T7 promoters, such as A1.

A1,A2,A3,BoxA region -- <bbpart>Z0294</bbpart>

Removed Host Promoters

B: Located mostly in gene 0.5, which is not encoded
C: Only -35 region is included within coding domain of gene 0.7; no further mutation necessary
E: Strong -10 region mutated, -35 region not included
S1: -35 and -10 regions edited to remove promoter
S2: -35 region edited, -10 region already nonoptimal
S3: -35 and -10 regions edited to remove promoter
S4: -35 and -10 regions edited to remove promoter
S5: Located within gene 5.3 which is not included
S6: -35 and -10 regions edited to remove promoter
F1: Only -35 region is included within coding domain of gene 6.5; no further mutation necessary
F2: -35 region mutated, -10 region already nonoptimal

Phage Promoters

We want to standardize the phage promoters that we encode onto the genome. In our models, we split the promoters into three class; weak binding and processivity, weak processivity, or strong promoters. The natural T7 promoters on the T7 genome are listed below, along the classification they fall into. The promoters in bold are the canonical promoter in each class that have the most kinetic studies associated with them. Thus we will use the three promoters in bold as the prototype sequences in each class that we will standardize the other promoters to.
øOL -- weak processivity (-11,1) -- standardized to <bbpart>Z0253</bbpart>
ø1.1A -- weak binding & processivity (-17,2,4) -- standardized to <bbpart>Z0252</bbpart>
ø1.1B -- weak processivity (3,4,5) -- standardized to <bbpart>Z0253</bbpart>
ø1.3 -- weak binding & processivity (-5,5) -- standardized to <bbpart>Z0252</bbpart>
ø1.5 -- weak processivity (-2,3,4,5) -- standardized to <bbpart>Z0253</bbpart>
ø1.6 -- weak processivity (-2,3,4,5,6) -- standardized to <bbpart>Z0253</bbpart>
ø2.5 -- weak processivity (-1,1,4,5) -- defined as <bbpart>Z0253</bbpart>
ø3.8 -- weak binding & processivity (-13,-12,-11,-2) -- defined as <bbpart>Z0252</bbpart>
ø4c -- weak binding & processivity (-17,-13,2) -- standardized to <bbpart>Z0252</bbpart>
ø4.3 -- weak processivity (-2,3,4,5,6) -- standardized to <bbpart>Z0253</bbpart>
ø4.7 -- weak binding & processivity (-17,-16,-13,3,4,5,6) -- standardized to <bbpart>Z0252</bbpart>
ø6.5 -- strong -- standardized to <bbpart>Z0251</bbpart>
ø9 -- strong -- standardized to <bbpart>Z0251</bbpart>
ø10 -- strong -- defined as <bbpart>Z0251</bbpart>
ø13 -- strong -- standardized to <bbpart>Z0251</bbpart>
ø17 -- strong -- standardized to <bbpart>Z0251</bbpart>
øOR -- strong -- standardized to <bbpart>Z0251</bbpart>

Terminators

We will keep our defiinitions for the terminators as they were in T7.1. TE and Tø will remain intact, while effort will be made to not alter the CJ terminator.

TE -- <bbpart>Z0271</bbpart>
Tø -- <bbpart>Z0272</bbpart>

RNA

RNaseIII sites

We will use the R0.3 as a standard RNaseIII site for all encoded RnaseIII sites in T7.2 (except R1.1, which lies in the primary origin of replication).

R0.3 -- <bbpart>Z0273</bbpart>

Miscellaenous Elements

Terminal Repeats

Left End -- <bbpart>Z0292</bbpart>
Right End -- <bbpart>Z0293</bbpart>

Primary Origin of Replication

The primary origin of replication is located at the phi1.1A/R1.1/phi1.1B locus. In order to not disturb this critical section of the T7 genome, we will not standardize the promoters or RNAseIII site located in this section.

Primary Origin of Replication -- <bbpart>Z0291</bbpart>

Other Changes

Reporters

DpnI optimization

Restriction enzyme considerations

Assemblies

Component Makeups

In Words

Left End -- Phi2.5 -- A1,A2,A3,BoxA -- R0.3 -- 0.3 -- R0.3 -- 0.7 -- R0.3 -- 1 -- ORI -- 1.1 -- 1.2 -- phi 3.8 -- R0.3 -- 1.3 -- TE -- phi2.5 -- 1.7 -- 2 -- phi2.5 -- 2.5 -- 3 -- 3.5 -- R0.3 -- phi3.8 -- 4A/B -- phi2.5 -- 4.3 -- 4.5 -- R0.3 -- phi3.8 -- 5 -- 5.5 -- 5.7 -- 6 -- R0.3 -- phi10 -- 6.5 -- 6.7 - 7.3 -- 8 -- phi10 -- 9 -- phi10 -- 10 -- Tphi -- 11 -- 12 -- R0.3 -- phi10 -- 13 -- 14 -- 15 -- 16 -- phi10 -- 17 -- 17.5 -- 18 -- R0.3 -- 18.5/18.7 -- 19/19.2/19.3 -- phi10 -- 19.5 -- Right End

In BioBrick Numbers

Z0292.Z0253.Z0294.Z0273.Z0261.Z0158.Z0273.Z0262.Z0106.Z0273.Z0262.Z0107.Z0291.Z0262. Z0108.Z0261.Z0115.Z0252.Z0273.Z0261.Z0109.Z0271.Z0253.Z0262.Z0151.Z0261.Z0116.Z0253. Z0262.Z0152.Z0262.Z0118.Z0262.Z0119.Z0273.Z0252.Z0262.Z0120.Z0253.Z0261.Z0138.Z0261. Z0139.Z0273.Z0252.Z0261.Z0121.Z0261.Z0160.Z0261.Z0154.Z0273.Z0251.Z0262.Z0159.Z0261. Z0123.Z0262.Z0124.Z0262.Z0125.Z0251.Z0262.Z0126.Z0251.Z0261.Z0127.Z0272.Z0261.Z0128. Z0262.Z0129.Z0273.Z0251.Z0262.Z0155.Z0262.Z0156.Z0262.Z0132.Z0262.Z0133.Z0251.Z0262. Z0134.Z0262.Z0157.Z0261.Z0136.Z0273.Z0261.Z0144.Z0262.Z0137.Z0251.Z0261.Z0148.Z0293

Initial Design

Initial Compilation: <bbpart>Z0501</bbpart>